Evgen Pharma PLC (AIM:EVG) CEO Dr Huw Jones speaks to Proactive from the sidelines of the BIO International Convention in Boston, MA, following the release of final results for the year to 31st March 2023.
Dr Jones gives his take on how the business performed over the twelve months, before moving on to talk about what the current year has in store.
He says the clinical stage drug development company is "very busy" at the start of an "exciting year."
He also thanks outgoing chief financial officer Richard Moulsen for his contribution to the company.